KDM4A and urinary bladder cancer: Conversely, genomic loss of KMD4A and concomitant decrease in mRNA levels has also been reported in multiple tumour types (Supplementary Fig. 6a–j)45, particularly bladder cancer where KDM4A downregulation correlates with tumour progression53.